Related Experiment Video
Updated: Oct 4, 2025

Dual CRISPR-Interference Strategy for Targeting Synthetic Lethal Interactions Between Non-Coding RNAs in Cancer Cells
Published on: May 30, 2025
The potential roles and mechanisms of non-coding RNAs in cancer anoikis resistance
Tongguo Shi1, Chuanqiang Zhang2, Suhua Xia3
1Jiangsu Institute of Clinical Immunology, The First Affiliated Hospital of Soochow University, 178 East Ganjiang Road, Suzhou, China. shitg@suda.edu.cn.
Abstract:
Increasing evidence indicates that anoikis resistance is a critical process for metastasis of cancer cells, making it the attractive therapeutic target for cancer benefit. Anoikis resistance is widely regulated by various factors, such as signaling pathways, integrins switch, and non-coding RNAs (ncRNAs). ncRNAs composed of microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), are frequently dysregulated in a variety of human malignancies and are closely related to anoikis resistance of cancer cells. Based on the available literature, we reviewed the molecular basis underlying ncRNAs modulating cancer cells anoikis resistance, which may contribute to a better understanding of cancer metastasis and provide new beneficial therapeutic strategies against cancer.
Insights
Cancer cells resist anoikis, a process crucial for metastasis, making it a therapeutic target. Non-coding RNAs (ncRNAs) like miRNAs, lncRNAs, and circRNAs significantly regulate this resistance, offering new treatment strategies.
Area of Science:
- Oncology
- Molecular Biology
- Cancer Research
Background:
- Anoikis resistance is a key driver of cancer cell metastasis.
- This resistance is regulated by signaling pathways, integrin switching, and non-coding RNAs (ncRNAs).
- ncRNAs, including microRNAs (miRNAs), long non-coding RNAs (lncRNAs), and circular RNAs (circRNAs), are often dysregulated in cancers.
Purpose of the Study:
- To review the molecular mechanisms of ncRNAs in modulating cancer cell anoikis resistance.
- To enhance understanding of cancer metastasis.
- To identify potential therapeutic strategies targeting ncRNAs for cancer treatment.
Main Methods:
- Literature review of existing studies on ncRNAs and anoikis resistance.
- Analysis of molecular pathways involved in ncRNA-mediated anoikis resistance.
- Synthesis of current knowledge on the role of miRNAs, lncRNAs, and circRNAs.
Main Results:
- ncRNAs play a significant role in the development and progression of anoikis resistance in cancer cells.
- Dysregulation of specific ncRNAs is linked to increased metastatic potential.
- Understanding these ncRNA roles provides insights into cancer cell survival mechanisms.
Conclusions:
- ncRNAs are critical regulators of anoikis resistance and cancer metastasis.
- Targeting ncRNAs presents a promising therapeutic avenue for overcoming cancer metastasis.
- Further research into ncRNA functions can lead to novel anti-cancer strategies.
Related Concept Videos
lncRNA - Long Non-coding RNAs
Adaptive Mechanisms in Cancer Cells
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Experimental RNAi
MicroRNAs
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

